Led by Primary Investigators, Rebekah Mannix, MD, MPH, William P. Meehan, MD, and Jianhua Qiu, MD, PhD, the lab’s goal is to illustrate the mechanisms of TBI-related neurodegeneration and find meaningful biomarkers for identifying, preventing, and treating short- and long-term effects of TBI. Our physician-scientists and team are actively collaborating with colleagues across the BCH research enterprise, as well as externally on numerous multicenter basic science and clinical research investigations. To learn more about our ongoing research, please visit our research projects page.